[Relation between the electronic structure of a series of 1,4-tetrahydro-oxazines and their p-D2, for the tryptaminergic receptor]. 1978

R Natcheva, and R Daudel, and G Dureng, and J Moleyre, and N Busch

Certain features of the isopotential maps of morpholine derivatives seem to be related to their ability to bind with tryptaminergic receptors.

UI MeSH Term Description Entries
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D010078 Oxazines Six-membered heterocycles containing an oxygen and a nitrogen.
D011985 Receptors, Serotonin Cell-surface proteins that bind SEROTONIN and trigger intracellular changes which influence the behavior of cells. Several types of serotonin receptors have been recognized which differ in their pharmacology, molecular biology, and mode of action. 5-HT Receptor,5-HT Receptors,5-Hydroxytryptamine Receptor,5-Hydroxytryptamine Receptors,Receptors, Tryptamine,Serotonin Receptor,Serotonin Receptors,Tryptamine Receptor,Tryptamine Receptors,Receptors, 5-HT,Receptors, 5-Hydroxytryptamine,5 HT Receptor,5 HT Receptors,5 Hydroxytryptamine Receptor,5 Hydroxytryptamine Receptors,Receptor, 5-HT,Receptor, 5-Hydroxytryptamine,Receptor, Serotonin,Receptor, Tryptamine,Receptors, 5 HT,Receptors, 5 Hydroxytryptamine
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

R Natcheva, and R Daudel, and G Dureng, and J Moleyre, and N Busch
June 1975, Journal of medicinal chemistry,
R Natcheva, and R Daudel, and G Dureng, and J Moleyre, and N Busch
October 2005, Current drug metabolism,
R Natcheva, and R Daudel, and G Dureng, and J Moleyre, and N Busch
February 2013, Journal of computer-aided molecular design,
R Natcheva, and R Daudel, and G Dureng, and J Moleyre, and N Busch
October 1985, Japanese journal of cancer research : Gann,
R Natcheva, and R Daudel, and G Dureng, and J Moleyre, and N Busch
January 2018, Organic & biomolecular chemistry,
R Natcheva, and R Daudel, and G Dureng, and J Moleyre, and N Busch
October 2021, Journal of medicinal chemistry,
R Natcheva, and R Daudel, and G Dureng, and J Moleyre, and N Busch
August 2008, Bioorganic & medicinal chemistry letters,
R Natcheva, and R Daudel, and G Dureng, and J Moleyre, and N Busch
January 2021, Journal of molecular modeling,
R Natcheva, and R Daudel, and G Dureng, and J Moleyre, and N Busch
December 1990, Physical review. B, Condensed matter,
R Natcheva, and R Daudel, and G Dureng, and J Moleyre, and N Busch
March 1997, Biochimica et biophysica acta,
Copied contents to your clipboard!